Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2021American Journal of HematologyOpen Access

Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMarion LamSorbonne UniversitéVTValérie TouitouNeurology, IncSCSylvain ChoquetSorbonne Université

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lam et al. (2021) studied this question.

synapsesocial.com/papers/6aaa431102d122af8757bf08https://doi.org/10.1002/ajh.26199
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term survival in primary CNS lymphoma.1998 · 581 citations
  2. 2High‐dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma2016 · 96 citations
  3. 3Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma2015 · 62 citations
  4. 4Treatment Strategies in Primary Vitreoretinal Lymphoma2014 · 155 citations
  5. 5Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma2013 · 57 citations